Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Elphogene, s.r.o. logo — Společnost poskytuje unikátní molekulární test oncoMonitor™...

Elphogene, s.r.o.

Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby nádorového onemocnění.

Founded 2018 Czech Republic Czech Republic 6 employees Seed Total: $500.00K Biotechnology, Health Care +1

General Information

Company Name Elphogene, s.r.o.
Founded Year 2018
Location Czech Republic Czech Republic +1
Employees 6
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

Get notified when Elphogene, s.r.o. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Elphogene, s.r.o.

Elphogene, s.r.o. is a Prague-based biotechnological start-up founded in 2018 as a spin-off from the Genomac Research Institute. The company's flagship project, oncoMonitor™, was introduced in 2019, aiming to monitor circulating tumor DNA (ctDNA) in cancer patients. The diagnostic tool, based on liquid biopsy, was developed in the Czech Republic after a decade of research and collaboration with leading oncology centers. The technology has shown promising results, capturing ctDNA in up to 88% of patients with advanced colorectal cancer and liver metastases. Elphogene, s.r.o. recently received a $250.00K Seed Round investment in April 2020 from i&i Prague. The company operates in the Biotechnology and Health Care industries, with a focus on advancing cancer diagnostics and treatment monitoring. This start-up's innovative approach to cancer care and the recent investment from i&i Prague position it as a promising player in the biotech industry.

Taxonomy: molecular diagnostics, oncology, liquid biopsy, ctDNA, cancer monitoring, cancer treatment, start-up, Genomac, technological innovation, clinical studies, Prague, spin-off company, metastatic cancer

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
01 Apr 2020
Pre Seed Round •••••• 1
Investor
05 Apr 2019

Elphogene, s.r.o. Alternatives & Competitors

Elphogene, s.r.o. vs
T3 Pharmaceuticals AG
T3 Pharmaceuticals AG Switzerland

Developing the next generation bacterial cancer therapy

Grant
25 employees
Biotechnology, Health and Wellness
Elphogene, s.r.o. vs
UbiVac
UbiVac United States

An Immunotherapy Company

Seed
6 employees
Elphogene, s.r.o. vs
Biotecnol Limited
Biotecnol Limited United Kingdom

Immunotherapies for Life

13 employees
Biotechnology, Health Care
Compare Elphogene, s.r.o. vs Biotecnol Limited

FAQ About Elphogene, s.r.o.

Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby nádorového onemocnění.
Elphogene, s.r.o. was founded in 2018.
Elphogene, s.r.o. is headquartered in Czech Republic.
Elphogene, s.r.o. operates in the following industries: Biotechnology, Health Care, Life Sciences.
Elphogene, s.r.o. has approximately 6 employees.
Elphogene, s.r.o. has completed 2 funding rounds, raising a total of $500.00K. The latest funding stage is Seed.
Top alternatives and competitors to Elphogene, s.r.o. include T3 Pharmaceuticals AG, UbiVac, Biotecnol Limited, TimeTeller GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elphogene, s.r.o. and T3 Pharmaceuticals AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Elphogene, s.r.o. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes